Sign in

CIK 0001653087

  • Accelerated filer
  • Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
822933343
Phone
+1 415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$296,087
in 3 filings

Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-17 GAROFALO ELIZABETH A. Director Grant or award +28,700 118,650
2026-06-17 GAROFALO ELIZABETH A. Director Grant or award · Stock Option (right to buy) +9,450 9,450
2025-06-11 GAROFALO ELIZABETH A. Director Grant or award +28,700 89,950
2025-06-11 GAROFALO ELIZABETH A. Director Grant or award · Stock Option (right to buy) +9,450 9,450
2024-06-12 GAROFALO ELIZABETH A. Director Grant or award +35,000 61,250
2023-12-05 GAROFALO ELIZABETH A. Director Gift −9,459 26,250
2023-06-14 GAROFALO ELIZABETH A. Director Grant or award +26,250 35,709
2023-06-14 GAROFALO ELIZABETH A. Director Grant or award · Stock Option (right to buy) +12,360 12,360
2022-06-16 GAROFALO ELIZABETH A. Director Grant or award +9,459 9,459
2022-06-16 GAROFALO ELIZABETH A. Director Grant or award · Stock Option (right to buy) +18,918 18,918
2021-09-23 GAROFALO ELIZABETH A. Director Grant or award · Stock Option (right to buy) +33,235 33,235

Page 1 of 1 · 11 trades